Skip to main content
. 2020 Jan 29;27(14):1529–1538. doi: 10.1177/2047487319901060

Table 1.

Baseline characteristics and screening abnormalities of athletes > 35 years screened for HRCC (n = 2578).

Athletes with screening abnormalities (n = 494)
n (%)
Baseline characteristics
 Male 396 (80.2)
Age, mean (range) in years 47.9 (36–79)
Ethnicity
 Caucasian 488 (98.8)
 African/Afro-Caribbean 3 (0.6)
 Other 3 (0.6)
Level of competition
 Elite (national/international competition) 7 (1.4)
 Competitive 249 (50.4)
 Recreational 238 (48.2)
 >6 weekly training hours 283 (57.3)
Screening abnormalities (Lausanne protocol)
History 415 (84.0)
Exercise-related complaintsa 381 (77.1)
Chest discomfort 111 (22.5)
Dyspnoea 93 (18.8)
Palpitations 103 (20.8)
Dizziness or fainting 32 (6.5)
Syncope 59 (11.9)
Abnormal fatigue 202 (40.9)
History of any CC 74 (15.0)
Family history SCA/SCD, inherited or congenital CC 165 (33.4)
Physical examination 155 (31.4)
Hypertension (>140/90 mm Hg) 70 (14.2)
Cardiac murmur 96 (19.4)
Peripheral vascular disease 3 (0.6)
Pectus excavatum 9 (1.8)
Resting 12-lead ECG
ESC-2005 criteria 308 (62.3)

CC: cardiovascular conditions; ECG: electrocardiogram; ESC: European Society of Cardiology; HRCC: high-risk cardiovascular conditions; SCA: sudden cardia arrest; SCD: sudden cardiac death.

a

Athletes had one or more exercise-related complaint.